Literature DB >> 19654413

Chemical approaches to nuclear receptors in metabolism.

Ronald N Margolis1, David D Moore, Timothy M Willson, R Kip Guy.   

Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored a workshop, "Chemical Approaches to Nuclear Receptors and Metabolism," in April 2009 to explore how chemical and molecular biology and physiology can be exploited to further our understanding of nuclear receptor structure, function, and role in disease. Signaling cascades involving nuclear receptors are more complex and interrelated than once thought. Nuclear receptors continue to be attractive targets for drug discovery. The overall goal of this workshop was to identify gaps in our understanding of the complexity of ligand activities and begin to address them by (i) increasing the collaboration of investigators from different disciplines, (ii) developing a better understanding of chemical modulation of nuclear receptor action, and (iii) identifying opportunities and roadblocks in the path of translating basic research to discovery of new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654413      PMCID: PMC5327858          DOI: 10.1126/scisignal.282mr5

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  27 in total

1.  Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation.

Authors:  Zoltan Arany; Bridget K Wagner; Yanhong Ma; Jessica Chinsomboon; Dina Laznik; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

Review 2.  Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies.

Authors:  R C Ribeiro; J W Apriletti; R L Wagner; B L West; W Feng; R Huber; P J Kushner; S Nilsson; T Scanlan; R J Fletterick; F Schaufele; J D Baxter
Journal:  Recent Prog Horm Res       Date:  1998

Review 3.  Interference of pollutants with PPARs: endocrine disruption meets metabolism.

Authors:  C Casals-Casas; J N Feige; B Desvergne
Journal:  Int J Obes (Lond)       Date:  2008-12       Impact factor: 5.095

4.  The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

Authors:  Kongming Wu; Sanjay Katiyar; Agnes Witkiewicz; Anping Li; Peter McCue; Liang-Nian Song; Lifeng Tian; Ming Jin; Richard G Pestell
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

5.  Nuclear receptors homo sapiens Rev-erbbeta and Drosophila melanogaster E75 are thiolate-ligated heme proteins which undergo redox-mediated ligand switching and bind CO and NO.

Authors:  Katherine A Marvin; Jeffrey L Reinking; Andrea J Lee; Keith Pardee; Henry M Krause; Judith N Burstyn
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

6.  Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.

Authors:  Andrew L LaFrate; Kathryn E Carlson; John A Katzenellenbogen
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

7.  Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening.

Authors:  Franck Madoux; Xiaolin Li; Peter Chase; Gina Zastrow; Michael D Cameron; Juliana J Conkright; Patrick R Griffin; Scott Thacher; Peter Hodder
Journal:  Mol Pharmacol       Date:  2008-03-11       Impact factor: 4.436

8.  The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation.

Authors:  Yvonne S Lin; Kazuto Yasuda; Mahfoud Assem; Cynthia Cline; Joe Barber; Chia-Wei Li; Vladyslav Kholodovych; Ni Ai; J Don Chen; William J Welsh; Sean Ekins; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

Review 9.  Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.

Authors:  Neil J McKenna; Austin J Cooney; Francesco J DeMayo; Michael Downes; Christopher K Glass; Rainer B Lanz; Mitchell A Lazar; David J Mangelsdorf; David D Moore; Jun Qin; David L Steffen; Ming-Jer Tsai; Sophia Y Tsai; Ruth Yu; Ronald N Margolis; Ronald M Evans; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2009-05-07

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.